Economic impact of using clodronate in the management of patients with multiple myeloma

The economic impact of using prophylactic clodronate as an adjunct to chemotherapy in the management of multiple myeloma for the first 4 years following diagnosis was established from the perspective of the National Health Service (NHS). A state‐transition model of the course of multiple myeloma was...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 1999-02, Vol.104 (2), p.358-364
Hauptverfasser:	Bruce, N. J., McCloskey, E. V., Kanis, J. A., Guest, J. F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic agents Biological and medical sciences bisphosphonates clodronate Clodronic Acid - economics Clodronic Acid - therapeutic use Combined treatments (chemotherapy of immunotherapy associated with an other treatment) Cost-Benefit Analysis costs Drug Costs Fractures, Bone - economics Fractures, Bone - therapy Health Resources - economics Health Resources - statistics & numerical data Hematology Humans Medical sciences multiple myeloma Multiple Myeloma - drug therapy Multiple Myeloma - economics Pharmacology. Drug treatments Recurrence resources Sensitivity and Specificity Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!